Aytu BioPharma Competitors and Similar CompaniesClear all
Aytu BioPharma's competitors and similar companies include Dabur and Shanghai RAAS.
 Aytu BioPharma Aytu BioPharma is initially concentrating on prostate cancer, male sexual dysfunction and male infertility and will expand into other urological indications through acquisition or licensing of approved, commercialized products and late-stage development assets. |  Shanghai RAAS Shanghai RAAS Blood Products (上海莱士血液制品股份有限公司) is a company researching, inventing, and developing products for the treatment of blood diseases. | ||
Founding Date | Founding Date N/A | Founding Date 1979 | Founding Date 1988 |
Type | Type Public | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations Englewood, US HQ | Locations HQ | Locations CN HQ |
Employees | Employees 537% decrease | Employees 1991% decrease | Employees 3,350 |
Valuation ($) | Valuation ($) 12.3 m | Valuation ($) N/A | Valuation ($) 6.8 b |
Financial | |||
Revenue (est.) | Revenue (est.) $66.4m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ¥7.3b (FY, 2025) |
Cost of goods | Cost of goods $20.6m (FY, 2025) | Cost of goods N/A | Cost of goods ¥4.6b (FY, 2025) |
Gross profit | Gross profit $45.8m (FY, 2025) | Gross profit N/A | Gross profit ¥2.7b (FY, 2025) |
Net income | Net income ($13.6m) (FY, 2025) | Net income N/A | Net income ¥1.6b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Shanghai RAAS
HQ
CN
Employees
3,350
Shanghai RAAS Blood Products (上海莱士血液制品股份有限公司) is a company researching, inventing, and developing products for the treatment of blood diseases.
View company